Skip to main content
Premium Trial:

Request an Annual Quote

Paul Colvin, Simon Britton, Consuelo Blosch, Dan Allison, Michael Torelli

PPD Names North America and Asia VPs in Expansion of Global Management Team
PPD, a global contract research organization based in Wilmington, NC, has named two new vice presidents in an expansion of its global management team:
  • Paul Colvin has been named senior vice president of clinical operations for North America, where he will oversee the company’s Phase II-IV operational unit. Colvin previously directed clinical operations and global patient enrollment optimization for Eli Lilly, capping 14 years of holding leadership positions with the pharma giant.
  • Simon Britton has been named vice president of clinical operations for Asia, a new senior management position. Britton spent the last seven years at GlaxoSmithKline where he most recently served as head of international clinical operations, managing the company's global clinical operations group across 25 countries.
With Britton's appointment, PPD has restructured its Phase II-IV operational units into four territories: North America; Latin America; Europe, the Middle East and Africa; and Asia.

VLST Names Clinical and Regulatory, Therapeutic Design Executives
VLST, a Seattle developer of therapeutics for autoimmune and inflammatory disorders, has named Consuelo Blosch as vice president of clinical and regulatory affairs and Dan Allison as senior director of therapeutic design.
Blosch previously served as administrative director of the Benaroya Research Institute at Virginia Mason’s clinical research program, and earlier held director-level positions at Immunex and NPS Pharmaceuticals. She received her MD from the University of Massachusetts Medical School.
From 1992 to 2007Allison worked as senior director of production development for Icos Corporation. Previously he worked at Genencor International. Allison received a PhD in genetics from the University of Washington and carried out postdoctoral studies in yeast cell biology at the Biozentrum in Basel, Switzerland, and in the biochemistry department at the University of Washington.

New York’s Empire State Development Corp. Names Mid-Hudson Regional Director
Michael Torelli has been named regional director for the mid-Hudson region of the Empire State Development Corporation, the economic development agency of New York state, effective Oct. 15. He succeeds Ronald Hicks, who left ESD earlier this year to become president and CEO of the Rockland Economic Development Corporation.
In his new position, Torelli will work with companies and local development agencies in the region, manage day-to-day operations for Empire State Development’s New Windsor and White Plains offices, and implement agency programs and projects.
Torelli previously served as director of business attraction for the public-private Orange County Partnership. From 1999 - 2002, he served as an account manager for ETC Data Services in Newburgh. Torelli was the inaugural recipient of the Orange County Rising Star Award in 2006, and is a founding member of the Alliance for Balanced Growth.  He earned a bachelor’s degree in business administration from the State University of New York-Brockport.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more